ACHE and congenital myasthenic syndrome: In some cases, treatments such as acetylcholinesterase inhibitors may be considered, particularly in patients with pathogenic variants in congenital myasthenia genes (CHRNA1, CHRND, DPAGT1, and GFPT1).